“…[3][4][5] Ketamine, a competitive NMDA receptor antagonist, prevents experimentally opioid-induced hyperalgesia, and ketamine in combination with morphine decreases both pain and morphine consumption during the postoperative period. [6][7][8][9] However, the optimal dosing and duration of ketamine administration remains to be determined. Low-dose ketamine induces a morphine-sparing effect when this administration is limited to the intraoperative period 10 or extended to the postoperative period, 11,12 but no study has compared the effects of intraoperative IV ketamine administration alone versus intraoperative and postoperative administration.…”